Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Evaluation of Ecallantide for the Acute Treatment of Angiotensin Converting Enzyme Inhibitor Induced Angioedema (ACE)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2012 by Bernstein, Jonathan A., M.D..
Recruitment status was  Recruiting
Dyax Corp.
Information provided by:
Bernstein, Jonathan A., M.D. Identifier:
First received: December 18, 2009
Last updated: March 8, 2012
Last verified: March 2012
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2013
  Estimated Primary Completion Date: June 2013 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):